Roy Baynes, Merck

Mer­ck­'s 15-strain pneu­mo­nia shot match­es Pre­vnar 13 in late-stage in­fant study, but Pfiz­er's next-gen shot looms

In or­der to keep the heat on Pfiz­er and its next-gen­er­a­tion pneu­mo­coc­cal vac­cine, Mer­ck knows it will need to get cre­ative to give its 15 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.